GOAL.MD review

GOAL.MD is most compelling for cash buyers who want to know the price before they fill out an intake and prefer to approve each compounded refill themselves. Its actual monthly prices are $179 for compounded semaglutide and $249 for compounded tirzepatide, with the medication, physician supervision, nutrition coaching and expedited shipping included. The much lower $99 and $159 headlines require a full year paid upfront. A separate $95 monthly physician-care program helps patients obtain branded medication through manufacturer channels, but the drug costs extra. The main reservation is billing clarity: the brand-access product page contains language about one-time payments that conflicts with the homepage and detailed membership terms describing automatic renewal. Get that program’s renewal arrangement confirmed in writing. Compounded orders also become nonrefundable when payment is processed, so approval of a reorder is a meaningful financial decision.

GOAL.MD describes itself as a physician-led telehealth practice founded in 2019 and veteran-owned. Its About page names Michael Mimlitz, MD, as chief physician and co-founder, with physicians Michael Fitch and Joel Jones also listed. These are the practice’s published identities rather than our independent credential verification. The service combines medical weight management with a wider menu of NAD+ and peptide treatments. Weight care has two distinct routes: patient-specific compounded injections, or physician supervision for a brand-name prescription purchased elsewhere. It advertises service in all 50 states but qualifies that statement by the patient’s clinical evaluation, individual medication rules and pharmacy eligibility. That qualification matters more than a nationwide marketing label. GOAL.MD says it is LegitScript certified and uses licensed U.S. 503A or 503B compounding pharmacies; the product pages reviewed did not establish which named pharmacy would fill a particular patient’s order.

The published process starts with a short online medical questionnaire, followed by review by a licensed physician who decides whether prescribing is appropriate. Approval is not guaranteed by completing the questionnaire or choosing a plan. The compounded package includes ongoing supervision and a dedicated nutrition coordinator, with unlimited nutrition coaching and shipping in the listed price. GOAL.MD says its care team contacts patients before their supply runs out so they can decide whether to reorder. This makes its compounded renewal model useful for someone who wants deliberate control over each purchase, although it also means the patient needs to answer refill communications early enough to avoid a gap. Telephone support is published for weekdays from 9 a.m. to 5 p.m. Central, alongside an email address; that is practical access to administrative help, not a promise that a physician is immediately available on the phone. Ask how clinical questions and side effects reach the prescriber, and what follow-up is included for your particular program.

Compounded semaglutide costs $179 month to month at every published dose. The three-month plan is $477 paid once, the six-month plan $834, and the twelve-month plan $1,188. Compounded tirzepatide costs $249 month to month; the corresponding prepaid totals are $597, $1,074 and $1,908. Those totals matter because the advertised monthly equivalents are not installment payments. GOAL.MD says compounded orders do not renew or charge automatically, but its terms also say a processed compounded order cannot be canceled or refunded. Brand-Name GLP-1 Access charges $95 for one month of physician services, or $255 every three months, $450 every six months and $780 every twelve months in the detailed membership terms. Medication, outside labs and outside services are additional. The homepage and terms describe an automatically renewing membership canceled before the next prescription or refill is authorized; one passage on the product page instead describes no automatic billing. That unresolved contradiction prevents treating the brand route as a simple one-time purchase. After payment and clinical work begin, that care fee is final and not prorated. The practice says it does not bill insurance directly.

The compounded weight-loss products are semaglutide and tirzepatide injections. The published price is unchanged across the listed titration steps, including tirzepatide through 15 mg, but those dose tables are descriptions of the offer rather than instructions for choosing a dose. A clinician must individualize the prescription. The brand-access route lists products such as Wegovy, Ozempic and Zepbound and points patients to manufacturer purchase programs, including NovoCare and LillyDirect. A prescription, program eligibility and the pharmacy’s actual price determine what the patient can obtain; the GOAL.MD physician fee does not purchase the drug. Compounded preparations are not FDA-approved, and a licensed pharmacy or a platform certification does not make them equivalent to an approved finished medicine. The wider longevity menu likewise should be evaluated treatment by treatment, rather than assuming a weight-care consultation establishes a benefit for NAD+ or peptides.